(Q49401699)

English

The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study.

scientific article published in March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study. (English)

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

1 reference

based on heuristic

inferred from title

insulin therapy

1 reference

based on heuristic

inferred from title

Josephine M. Egan

5

object named as

Josephine M Egan

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

author name string

Panagis Galiatsatos

1

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

B Robert Gibson

2

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

Atoosa Rabiee

3

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

Olga Carlson

4

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

Richard P Shannon

6

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

Dana K Andersen

7

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

Dariush Elahi

8

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

language of work or name

0 references

publication date

1 March 2014

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

Critical Care Medicine

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

42

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

3

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

638-645

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

Exogenous glucagon-like peptide-1 for hyperglycemia in critically ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

22 May 2018

Hypoglycemia and outcome in critically ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

22 May 2018

Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

22 May 2018

Incretins in the ICU: is insulin on its way out?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

22 May 2018

Efficacy of a continuous GLP-1 infusion compared with a structured insulin infusion protocol to reach normoglycemia in nonfasted type 2 diabetic patients: a clinical pilot trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

22 May 2018

The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

22 May 2018

Clinical review: The extrapancreatic effects of glucagon-like peptide-1 and related peptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

22 May 2018

Benefits and risks of tight glucose control in critically ill adults: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

22 May 2018

The multiple faces of glucagon-like peptide-1--obesity, appetite, and stress: what is next? A review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

22 May 2018

Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

22 May 2018

Intensive insulin therapy in critically ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

22 May 2018

The glucagon-like peptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

22 May 2018

The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

22 May 2018

Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

14 August 2018

Intensive insulin therapy confers a similar survival benefit in the burn intensive care unit to the surgical intensive care unit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

14 August 2018

Intensive versus conventional glucose control in critically ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

14 August 2018

Effects of intravenous glucagon-like peptide-1 on glucose control and hemodynamics after coronary artery bypass surgery in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

14 August 2018

GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

14 August 2018

Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

14 August 2018

Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

14 August 2018

Effects of 3 Months of Continuous Subcutaneous Administration of Glucagon-Like Peptide 1 in Elderly Patients With Type 2 Diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

14 August 2018

Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

14 August 2018

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

14 August 2018

Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

14 August 2018

Intensive insulin therapy in the ICU—reconciling the evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5794001

1 December 2018

Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control

1 reference

https://pubmed.ncbi.nlm.nih.gov/24247476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting

1 reference

https://pubmed.ncbi.nlm.nih.gov/24247476

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/CCM.0000000000000035

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

1 reference

Europe PubMed Central

20 February 2018

http://europepmc.org/abstract/PMC/5794001

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49401699&oldid=1562187118"